Western blot analysis confirmed that S-GLSP significantly suppressed the expression of phosphorylated tau (p-tau) (Figures 3G,H), indicating its ability to modulate a key AD-related pathogenic process. This evidence concerns the gene MAPT and Alzheimer disease.